SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer and the 5-year relative overall survival (OS) rate is less than 20%. Since there are no specific symptoms, most patients with HCC are diagnosed in an advanced stage with poor prognosis. Therefore, identifying novel progn...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2023-11-01
|
| Rangatū: | European Journal of Medical Research |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s40001-023-01347-5 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|